ГЕМАТУРИЯ В ПРАКТИКЕ ТЕРАПЕВТА



DOI: http://dx.doi.org/10.25298/2221-8785-2020-18-2-187-192


Ю. И. Карпович (Y. I. Karpovich), В. М. Пырочкин (V. M. Pyrochkin), В. А. Снежицкий (V. A. Snezhitskiy), Н. А. Нечипоренко (N. A. Nechiporenko), Е. В. Зубко (E. V. Zubko), Ю. Л. Карпович (Y. L. Karpovich), В. Ч. Богданович (V. Ch. Bogdanovich), С. С. Миклаш (S. S. Miklash)

Аннотация


В настоящей публикации рассматривается диагностическая тактика при выявлении у пациента макрогематурии, с поиском причин и формулированием соответствующих рекомендаций.


Ключевые слова


гематурия; псевдогематурия

Полный текст:

Литература


Дифференциальный диагноз мочевого синдрома: эритроцитурия / Д. И. Трухан [и др.] // Международный журнал прикладных и фундаментальных исследований. – 2017. – № 2-1. – С. 28-32.

Truhan DI, Bagisheva NV, Goloshubina VV, Konshu NV. Differencialnyj diagnoz mochevogo sindroma: jeritrociturija. [Differential diagnosis urinary syndrome: erythrocyteuria]. Mezhdunarodnyj zhurnal prikladnyh i fundamentalnyh issledovanij. 2017;2-1:28-32. (Russian).

Glomerular Hematuria: Cause or Consequence of Renal Inflammation? / J. A. Moreno [et al.] // International Journal of Molecular Sciences. – 2019. – Vol. 20 (9). – P. 2205. – doi: 10.3390/ijms20092205.

Moreno JA, Sevillano Á, Gutiérrez E, Guerrero-Hue M, Vázquez-Carballo C, Yuste C, Herencia C, García- Caballero C, Praga M, Egido J. Glomerular Hematuria: Cause or Consequence of Renal Inflammation? International Journal of Molecular Sciences. 2019;20(9):2205. doi: 10.3390/ijms20092205.

Polito, M. G. An overview on frequency of renal biopsy diagnosis in Brazil: Clinical and pathological patterns based on 9617 native kidney biopsies / M. G. Polito, L. A. R. de Moura, G. M. Kirsztajn // Nephrology Dialysis Transplantation. – 2010. – Vol. 25 (2). – P. 490–496. – doi: 10.1093/ndt/gfp355.

Polito MG, de Moura LAR, Kirsztajn GM. An overview on frequency of renal biopsy diagnosis in Brazil: Clinical and pathological patterns based on 9617 native kidney biopsies. Nephrology Dialysis Transplantation. 2010;25(2):490–496. doi: 10.1093/ndt/gfp355.

Brodsky, S. Anticoagulant-Related Nephropathy / S. Brodsky, J. Eikelboom, L. A. Hebert // Journal of the American Society of Nephrology. – 2018. – Vol. 29 (12). – P. 2787–2793. – doi: 10.1681/asn.2018070741.

Brodsky S, Eikelboom J, Hebert LA. Anticoagulant-Related Nephropathy. Journal of the American Society of Nephrology. 2018;29(12):2787–2793. doi: 10.1681/ asn.2018070741.

Hematuria as a risk factor for progression of chronic kidney disease and death: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study / P. F. Orlandi [et al.] // BMC Nephrology. – 2018. – Vol. 19 (1). – P. 150. – doi: 10.1186/s12882-018-0951-0.

Orlandi PF, Fujii N, Roy J, Chen HY, Lee Hamm L, Sondheimer JH, He J, Fischer MJ, Rincon-Choles H, Krishnan G, Townsend R, Shafi T, Hsu CY, Kusek JW, Daugirdas JT, Feldman HI. Hematuria as a risk factor for progression of chronic kidney disease and death: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrology. 2018;19(1):150. doi: 10.1186/s12882-018-0951-0.

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120 / G. Schulman [et al.] // Clinical and Experimental Nephrology. – 2018. – Vol. 22 (2). – P. 299–308. – doi: 10.1007/s10157-017-1447-0.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Kikuchi M, Shobu Y. Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120. Clinical and Experimental Nephrology. 2018;22(2):299–308. doi: 10.1007/s10157-017-1447-0.

AKI Associated with Macroscopic Glomerular Hematuria: Clinical and Pathophysiologic Consequences / J. A. Moreno [et al.] // Clinical Journal of the American Society of Nephrology. – 2012. – Vol. 7 (1). – P. 175–184. – doi: 10.2215/cjn.01970211.

Moreno JA, Martín-Cleary C, Gutiérrez E, Toldos O, Blanco-Colio LM, Praga M, Ortiz A, Egido J. AKI Associated with Macroscopic Glomerular Hematuria: Clinical and Pathophysiologic Consequences. Clinical Journal of the American Society of Nephrology. 2012;7(1):175–184. doi: 10.2215/cjn.01970211.

Podocytes are new cellular targets of haemoglobinmediated renal damage / A. Rubio-Navarro [et al.] // Journal of Pathology. – 2018. – Vol. 244 (3). – P. 296–310. – doi: 10.1186/s12882-018-0951-0.

Rubio-Navarro A, Sanchez-Niño MD, Guerrero-Hue M, García-Caballero C, Gutiérrez E, Yuste C, Sevillano Á, Praga M, Egea J, Román E, Cannata P, Ortega R, Cortegano I, de Andrés B, Gaspar ML, Cadenas S, Ortiz A, Egido J, Moreno JA. Podocytes are new cellular targets of haemoglobin-mediated renal damage. Journal of Pathology. 2018:244(3):296–310. doi: 10.1186/s12882-018-0951-0.

Heme as a Target for Therapeutic Interventions / S. Immenschuh [et al.] // Frontiers in Pharmacology. – 2017. – Vol. 8. – P. 146. – doi: 10.3389/fphar.2017.00146.

Immenschuh S, Vijayan V, Janciauskiene S, Gueler F. Heme as a Target for Therapeutic Interventions. Frontiers in Pharmacology. 2017;8:146. doi: 10.3389/fphar.2017.00146.

Management and treatment of glomerular diseases (part 1): Conclusions from a Kidney Disease: Improving

Global Outcomes (KDIGO) Controversies Conference / J. Floege [et al.] // Kidney International. – 2019. – Vol. 95. – P. 268–280.

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH. Management and treatment of glomerular diseases (part 1): Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 2019;95:268–280.


Ссылки

  • На текущий момент ссылки отсутствуют.